Botulinum Toxin Type A in Combination With Standard Urotherapy for Children With Dysfunctional Voiding

Journal of Urology

Volumn 178, Issue 6, 2007, Pages 2599-2603

  Petronijevic, Vesna ^a   Lazovic, Milica ^a   Vlajkovic, Marina ^b   Slavkovic, Andjelka ^b   Golubovic, Emilija ^b   Miljkovic, Predrag ^b  

^a Rehabilitation and Prosthetics   (Serbia)

^b Clinical Centre Nis   (Serbia)

Author keywords

artificial; botulinum toxin type A; urinary sphincter; urination disorders

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A;

ARTICLE; BLADDER SPHINCTER; CHILD; CLINICAL ARTICLE; DRUG ADMINISTRATION ROUTE; FEMALE; HUMAN; INTERNATIONAL REFLUX STUDY IN CHILDREN MODIFIED QUESTIONNAIRE; MICTURITION; MICTURITION DISORDER; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RESIDUAL URINE; SCORING SYSTEM; SYMPTOMATOLOGY; TRANSPERINEAL DRUG ADMINISTRATION; TREATMENT RESPONSE; UROFLOWMETRY;

ADMINISTRATION, INTRAVESICAL; BOTULINUM TOXIN TYPE A; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; URINARY INCONTINENCE; URINARY RETENTION; URINATION; URINATION DISORDERS; URODYNAMICS;

EID: 36048998456     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.08.027     Document Type: Article

References (11)

1. Shoulte-Baukloh H., Michael T., Schobert J., Stolze T., and Knispel H.H. Efficacy of botulinum-A toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary reports. Urology 59 (2002) 325
2. Hoebeke P., De Caestecker K., Vande Walle J., Dehoorne J., Raes A., Verleyen P., et al. The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor. J Urol 176 (2006) 328
3. Radojicic Z., Perovic S., and Milic N. Is it reasonable to treat refractory voiding dysfunction in children with botulinum-A toxin. J Urol 176 (2006) 332
4. Riccabona M., Koen M., Schindler M., Goedele B., Pycha A., and Lusuardi L. Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 171 (2004) 845
5. Koff S.A. Estimating bladder capacity in children. Urology 21 (1983) 248
6. Kuo H.C. Effect of botulinum A toxin in the treatment of voiding dysfunction due to detrusor underactivity. Urology 61 (2003) 550
7. Schurch B., Hodler J., and Rodic B. Botulinum A toxin as a treatment of detrusor-sphincter dyssynergia in patients with spinal cord injury: MRI controlled transperineal injections. J Neurol Neurosurg Psychiatry 63 (1997) 474
8. Wyndaele J.J., and Van Dromme S.A. Muscle weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity. Spinal Cord 40 (2002) 599
9. Bakheit A.M., Severa S., Cosgrove A., Morton R., Roussounis S.H., Doderlein L., et al. Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticity. Dev Med Child Neurol 43 (2001) 234
10. van Gool J.D., Hjalmas K., Tamminen-Mobius T., and Olbing H. Historical clues to the complex of dysfunctional voiding, urinary tract infection and vesicoureteral reflux. The International Reflux Study in Children. J Urol 148 (1992) 1699
11. Akbal C., Genc Y., Burgu B., Ozden E., and Tekgul S. Dysfunctional voiding and incontinence scoring system: quantitative evaluation of incontinence symptoms in pediatric population. J Urol 173 (2005) 969